Impact of vaccination and early monoclonal antibody therapy on coronavirus disease 2019 outcomes in organ transplant recipients during the Omicron wave

…, BG Árbol, A Alshahrani, I Bahinskaya… - Clinical Infectious …, 2022 - academic.oup.com
Background Solid organ transplant (SOT) recipients are at high risk for complications from
coronavirus disease 2019 (COVID-19) and vaccine breakthrough infections are common. We …

Prevention of viral transmission during lung transplantation with hepatitis C-viraemic donors: an open-label, single-centre, pilot trial

…, M Kuczynski, D Kumar, I Bahinskaya… - The Lancet …, 2020 - thelancet.com
Background A substantial proportion of organ donors test positive for hepatitis C virus (HCV)
infection. To date, only a few studies have evaluated the safety of using lungs from these …

[HTML][HTML] Short-course early outpatient remdesivir prevents severe disease due to COVID-19 in organ transplant recipients during the omicron BA. 2 wave

JT Solera, BG Árbol, I Bahinskaya, N Marks… - American Journal of …, 2023 - Elsevier
Solid organ transplant recipients (SOTr) remain at risk of severe COVID-19. Several previous
early therapies are no longer effective against new circulating variants. We performed a …

Short-course, direct-acting antivirals and ezetimibe to prevent HCV infection in recipients of organs from HCV-infected donors: a phase 3, single-centre, open-label …

…, N Marks, N Kamkar, I Bahinskaya… - The Lancet …, 2020 - thelancet.com
Background An increasing percentage of potential organ donors are infected with hepatitis C
virus (HCV). After transplantation from an infected donor, establishment of HCV infection in …

[HTML][HTML] Prospective observational study and serosurvey of SARS-CoV-2 infection in asymptomatic healthcare workers at a Canadian tertiary care center

…, T Ku, B Majchrzak-Kita, ST Humar, I Bahinskaya… - PLoS …, 2021 - journals.plos.org
Health care workers (HCWs) are at higher risk for SARS-CoV-2 infection and may play a role
in transmitting the infection to vulnerable patients and members of the community. This is …

[HTML][HTML] Improving our mechanistic understanding of the indirect effects of CMV infection in transplant recipients

AG L'Huillier, VH Ferreira, T Ku, I Bahinskaya… - American Journal of …, 2019 - Elsevier
Cytomegalovirus (CMV) is an immunomodulatory virus that indirectly increases the risk for
bacterial, fungal, and viral infections. However, the pathogenesis of this phenomenon is …

[HTML][HTML] Impact of vaccination and early monoclonal antibody therapy on coronavirus disease 2019 (COVID-19) outcomes in organ transplant recipients during the …

…, BG Árbol, A Alshahrani, I Bahinskaya… - … Diseases: An Official …, 2022 - ncbi.nlm.nih.gov
Background Solid organ transplant (SOT) recipients are at high risk for complications from
coronavirus disease 2019 (COVID-19) and vaccine breakthrough infections are common. We …

[HTML][HTML] Longitudinal outcomes of COVID-19 in solid organ transplant recipients from 2020 to 2023

…, A Mittal, V Hall, T Marinelli, I Bahinskaya… - American Journal of …, 2024 - Elsevier
Data regarding coronavirus disease 2019 (COVID-19) outcomes in solid organ transplant
recipients (SOTr) across severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …

COVID-19 reinfection has better outcomes than the first infection in solid organ transplant recipients

…, A Mittal, VG Hall, T Marinelli, I Bahinskaya… - …, 2023 - journals.lww.com
Background. Solid organ transplant recipients face an increased risk of severe coronavirus
disease 2019 (COVID-19) and are vulnerable to repeat severe acute respiratory syndrome …

Prospective observational study of screening asymptomatic healthcare workers for SARS-CoV-2 at a Canadian tertiary care center

…, T Ku, B Majchrzak-Kita, ST Humar, I Bahinskaya… - medRxiv, 2020 - medrxiv.org
We screened three separate cohorts of healthcare workers for SARS-CoV-2 via nasopharyngeal
swab PCR. A seroprevalence analysis using multiple assays was performed in a …